Lv4
750 积分 2021-01-04 加入
Addition of Low-Dose Decitabine to Anti–PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma
1个月前
已完结
Epigenetic Silencing of MTAP in Hodgkin's Lymphoma Renders It Sensitive to a 2 nd Generation PRMT5 Inhibitor
1个月前
已关闭
Affinity Maturation of Monoclonal Antibodies by Multi-Site-Directed Mutagenesis
2个月前
已完结
Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods
2个月前
已完结
SUMO: In Silico Sequence Assessment Using Multiple Optimization Parameters
2个月前
已完结
Single-Domain Antibodies
2个月前
已完结
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
3个月前
已完结
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
3个月前
已完结
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
3个月前
已完结
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
3个月前
已完结
皖公网安备34019202002308
